PRISM BioLab Co.,LTD (206A.T)
JPY 244.0
(-4.69%)
JPY 244.0
(-4.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -496.86 Million JPY | -845.14% |
| 2022 | 66.68 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -208.79 Million JPY | 0.0% |
| 2023 FY | -496.86 Million JPY | -845.14% |
| 2022 FY | 66.68 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 183.252% |
| GNI Group Ltd. | 13.1 Billion JPY | 103.79% |
| Linical Co., Ltd. | 725.72 Million JPY | 168.465% |
| Trans Genic Inc. | 89.43 Million JPY | 655.557% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 65.155% |
| Soiken Holdings Inc. | -610 Million JPY | 18.547% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | 35.701% |
| AnGes, Inc. | -11.96 Billion JPY | 95.848% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | 55.668% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 94.784% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 576.388% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | 42.52% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | 55.517% |
| CanBas Co., Ltd. | -1.26 Billion JPY | 60.629% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | 37.779% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -47.279% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | 58.772% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 62.798% |
| PeptiDream Inc. | 6.77 Billion JPY | 107.336% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 74.255% |
| Ribomic Inc. | -1.11 Billion JPY | 55.485% |
| SanBio Company Limited | -4.53 Billion JPY | 89.053% |
| Healios K.K. | -3.37 Billion JPY | 85.295% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | 56.984% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 64.344% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 64.585% |
| StemRIM | -2.07 Billion JPY | 76.066% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 140.677% |
| FunPep Company Limited | -994 Million JPY | 50.013% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 44.094% |
| Stella Pharma Corporation | -760.3 Million JPY | 34.648% |
| TMS Co., Ltd. | -943.25 Million JPY | 47.324% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | 35.92% |
| Cuorips Inc. | -588.48 Million JPY | 15.569% |
| K Pharma,Inc. | 366.05 Million JPY | 235.735% |
| Takara Bio Inc. | 3 Billion JPY | 116.546% |
| ReproCELL Incorporated | -409.29 Million JPY | -21.397% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 4591.259% |
| StemCell Institute Inc. | 413.75 Million JPY | 220.086% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 443.837% |
| CellSeed Inc. | -697.77 Million JPY | 28.793% |